Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1Phase 2/3 1

Status

Not yet recruiting 2Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Endocrine 5

Conditions

Colorectal Neoplasms 491Rectal Neoplasms 267Colonic Neoplasms 218Pancreatic Neoplasms 186Stomach Neoplasms 181Esophageal Neoplasms 134Breast Neoplasms 118Neoplasm Metastasis 116Squamous Cell Carcinoma of Head and Neck 94Head and Neck Neoplasms 92Neoplasms 88Adenocarcinoma Of Esophagus 67Esophageal Squamous Cell Carcinoma 61Carcinoma, Hepatocellular 54Adenocarcinoma 40Nasopharyngeal Carcinoma 33Cholangiocarcinoma 32Biliary Tract Neoplasms 26Anus Neoplasms 26Gastrointestinal Neoplasms 25Carcinoma, Squamous Cell 25Carcinoma, Non-Small-Cell Lung 25Keratosis, Actinic 22Gallbladder Neoplasms 21Urinary Bladder Neoplasms 20Parkinson Disease 4, Autosomal Dominant Lewy Body 20Liver Neoplasms 20Bile Duct Neoplasms 19Ovarian Neoplasms 16Carcinoma 16

Interventions

Cisplatin 12Everolimus 10Nivolumab 8Etoposide 8Temozolomide 6Carboplatin 6atezolizumab 5Irinotecan 5Ipilimumab 5Fluorouracil 5Bevacizumab 5pembrolizumab 4lutetium Lu 177 dotatate 4Capecitabine 4avelumab 3Paclitaxel 3IFL protocol 3surufatinib 2sintilimab 2dostarlimab 2cabozantinib 2belinostat 2azaspirane 2Topotecan 2Radiosurgery 2Positron Emission Tomography Computed Tomography 2PE regimen 2N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2Magnetic Resonance Imaging 2Leucovorin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Neuroendocrine × Fluorouracil × Clear all
NCT07595913 2026-05-19

A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Phase 3 Not yet recruiting
240 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT07014540 2025-06-11

A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma

Beijing GoBroad Hospital

Phase 4 Not yet recruiting
45 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT03387592 2025-03-10

SENECA

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase 2 Terminated
53 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT03837977 2024-12-30

NET02

The Christie NHS Foundation Trust

Phase 2 Completed
58 enrolled
Endocrine

Neoplasms, Carcinoma, Neuroendocrine

NCT03992911 2019-06-20

Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma

Peking University

Phase 2/3 Unknown
336 enrolled
Endocrine

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡